If you have taken Abilify and have suffered harm from any type of compulsive behavior, it is vital that you contact an Abilify compulsive gambling lawyer immediately to discuss your potential Abilify lawsuit.

One of these behaviors is compulsive gambling which has caused severe problems in the lives of those who have experienced it.Īs a result, the manufacturer of the drug is now facing over 2,000 lawsuits for this alleged side effect after settling various other lawsuits that had been filed.

However, Abilify has been associated with a number of compulsive behaviors in patients who are taking the drug.

The drug can also be used as an add-on to another antipsychotic drug that a patient is taking in order to boost the effectiveness of that other drug.

The GENERIC NAME for Abilify medicine is Aripiprazole.

Abilify is an atypical antipsychotic drug that is intended to treat a variety of mental and mood disorders.

Some data indicates that Abilify can increase the risk of childhood diabetes by a factor of seven.Abilify Compulsive Gambling Lawsuit- What You Need to Know At the average doses, Abilify may increase the risk of diabetes 7.72 percent above normal.Ībilify childhood diabetes can pose serious long-term health risks, which follow children into adulthood and for the rest of their lives. That compares with only 0.76 per 1,000 children not given an antipsychotic. In a 2011 study, researchers found that after using antidepressants for just 4.5 months, 3.23 out of every 1,000 children developed diabetes. It is known that Abilify may cause weight gain, and the medication also poses an unreasonable risk of diabetes for children. However, doctors and patients suggest that Abilify is being provided more and more as a cure for behavioral problems of all kinds, resulting in overuse and children being unnecessarily exposed to the drug’s side effects. In recent years, concerns have emerged about the widespread use of the drug among children, especially given the potential link between Abilify and diabetes.Ĭritics suggest that the drugs are meant to provide stability to adolescents, while the underlying problems are treated through counseling and other means. The manufacturer, Otsuka Pharmaceutical Co., has promoted the drug through aggressive direct-to-consumer advertisements. The drug is part of a class of medications known as atypical antipsychotics, and it has become one of the top selling antipsychotic medications in recent years, particularly since it does not yet face competition from generic versions. It was approved by the FDA in 2002, for the treatment of a number of psychological problems, including schizophrenia, bipolar disorder, depression and autism in adults and children. Abilify Childhood Diabetes ProblemsĪbilify (aripiprazole) is one of the best selling drugs in the world, with 2013 sales estimated at more than $6 billion worldwide. As a result, potential Abilify childhood diabetes lawsuit were evaluated. Research has found that side effects of Abilify may increase the risk of childhood diabetes and the risk of weight gain, posing serious life-long health consequences for young children prescribed the atypical antipsychotic.Īlthough it appears that the makers of the drug knew or should have known about the risk of diabetes from Abilify, inadequate warnings were provided about the risk for kids using the medication.

However, cases are no longer being pursued by your law firm. previously reviewed potential product liability lawsuits for children diagnosed with diabetes following use of the popular antipsychotic Abilify.

Camp Lejeune Water Contamination Lawsuit.

Abilify class actio lawsuit